E-Therapeutics Plc buy melinda
Start price
02.12.21
/
50%
€0.49
Target price
02.12.22
-
Performance (%)
-48.98%
End price
03.12.22
€0.25
Summary
This prediction ended on 03.12.22 with a price of €0.25. Massive losses of -48.98% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
E-Therapeutics Plc | - | - | - |
iShares Core DAX® | 1.051% | -1.833% | 12.822% |
iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to melinda what are the pros and cons of E-Therapeutics Plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread E-Therapeutics Plc diskutieren
Buy E-Therapeutics Plc
In the thread Trading E-Therapeutics Plc
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for E-Therapeutics Plc
E-Therapeutics Plc
Start price
Target price
Perf. (%)
€0.13
11.02.20
11.02.20
-
04.11.21
04.11.21
266.80%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year